I
I. Llorente
Researcher at Autonomous University of Madrid
Publications - 33
Citations - 235
I. Llorente is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 7, co-authored 28 publications receiving 113 citations.
Papers
More filters
Journal ArticleDOI
Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
TL;DR: The relationship between different factors involved in the development of osteoporosis in RA patients, both the classic factors and the most novel, are unraveled, based on the relationship of autoantibodies with bone remodeling.
Journal ArticleDOI
Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.
I. Llorente,Leticia Merino,Ana M. Ortiz,Eugenio Escolano,Saturnino González-Ortega,Rosario García-Vicuña,Jesús A. García-Vadillo,Santos Castañeda,Isidoro González-Álvaro +8 more
TL;DR: The data reinforce the previous preclinical findings suggesting that the systemic bone loss detected at the initial phases of early ACPA-positive arthritis is independent of inflammatory status and, therefore, could be mediated by ACPA.
Journal Article
Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis
Santos Castañeda,Sara Remuzgo-Martínez,Raquel López-Mejías,Fernanda Genre,Jaime Calvo-Alén,I. Llorente,Elena Aurrecoechea,Ana M. Ortiz,Ana Triguero,Ricardo Blanco,Javier Llorca,Miguel A. González-Gay +11 more
TL;DR: The intravenous administration of tocilizumab yields a rapid beneficial effect on IR and insulin sensitivity in non-diabetic RA patients, and support the potential beneficial effect of the IL-6 blockade on the mechanisms associated with the development of metabolic syndrome and cardiovascular disease in patients with RA.
Journal ArticleDOI
Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.
Diego A Rodríguez-Serrano,Emilia Roy-Vallejo,Nelly D. Zurita Cruz,Alexandra Martin Ramirez,Sebastián C Rodríguez-García,Nuria Arevalillo-Fernandez,José María Galván-Román,Leticia Fontan Garcia-Rodrigo,Lorena Vega-Piris,Marta Chicot Llano,David Arribas Mendez,Begona Gonzalez de Marcos,Julia Hernando Santos,Ana Sánchez Azofra,Elena Avalos Perez-Urria,Pablo Rodriguez-Cortes,Laura Esparcia,Ana Marcos-Jimenez,Santiago Sánchez-Alonso,I. Llorente,Joan B. Soriano,Carmen Suárez Fernández,Rosario García-Vicuña,Julio Ancochea,Jesús Sanz,Cecilia Muñoz-Calleja,Rafael de la Cámara,Alfonso Canabal Berlanga,Isidoro González-Álvaro,Laura Cardeñoso +29 more
TL;DR: In this paper, SARS-CoV-2 RNA detection in serum as a severity biomarker in COVID-19 was performed with samples collected at 48-72 h of admission by two techniques from Roche and Thermo Fischer Scientific (TFS).
Journal ArticleDOI
Multicenter registry on inflammatory myositis from the Rheumatology Society in Madrid, Spain: Descriptive Analysis.
Laura Nuño,Beatriz Joven,Patricia Carreira,Valentina Maldonado,Carmen Larena,I. Llorente,Eva Tomero,María Carmen Barbadillo,Paloma García de la Peña,L. Ruiz,Juan Carlos López-Robledillo,Henry Moruno,Ana Fernández Pérez,Tatiana Cobo-Ibáñez,Raquel Almodóvar,L. Lojo,Indalecio Monteagudo,María Jesús García-De Yébenes,Francisco Javier López-Longo +18 more
TL;DR: In this paper, the authors analyzed clinical characteristics, survival and causes of death of patients diagnosed with inflammatory myositis in the REMICAM registry from the Society of Rheumatology in the Community of Madrid.